OBJECTIVES The aim of this study was to evaluate the pathophysiological features and response to primary percutaneous coronary intervention (PCI) of nonruptured/eroded plaque versus ruptured plaque as a cause of ST-segment elevation myocardial infarction (STEMI).
Postmortem data highlighted that a ruptured plaque is by far the most common cause of coronary thrombosis in acute myocardial infarction (3, 6) .
Conversely, nonruptured/eroded plaque, the second cause of coronary thrombosis in ex vivo series, is characterized by endoluminal thrombosis without evidence of plaque rupture in serial sectioning of the arterial segment (3, (6) (7) (8) . However, pathology studies are limited by the potential patient selection bias, and they cannot assess the impact of plaque phenotypes on the results of coronary interventions. Therefore, in patients presenting with STEMI, the incidence, the biological characteristics, and the clinical impact associated with different culprit plaque morphologies remain unclear.
Optical coherence tomography (OCT) in patients with acute coronary syndromes allows accurate in vivo detection and measurements of culprit plaque with intact fibrous cap (IFC) and with ruptured fibrous cap (RFC), intracoronary thrombus, thin-cap fibroatheroma (TCFA), and the healing response to stent implantation, being closely correlated with pathology (9) . In patients with STEMI, OCT has been shown to be safe and superior to other intravascular imaging modalities for plaque differentiation (10, 11) .
The objectives of this prospective, multicenter study in patients presenting with STEMI were the following: 1) to define the incidence of different culprit plaque morphologies detected by OCT in clinical practice;
2) to assess clinical characteristics, plaque features, and serum components associated with IFC compared with RFC; and 3) to compare the acute and chronic vascular response to current-generation drug-eluting stents implanted in patients with IFC versus RFC.
METHODS
STUDY DESIGN AND POPULATION. The present study, which focused on the comparison of patients presenting with IFC versus RFC at the culprit site of STEMI, represents a pre-specified analysis of the OCTAVIA (Optical Coherence Tomography Assessment of Gender Diversity in Primary Angioplasty) trial (12) . The full study design and methodology were previously reported (12) . In brief, the OCTAVIA trial was a prospective, multicenter, investigator-driven trial that enrolled 140 STEMI patients presenting 93.7%; p < 0.001). Table 4) .
ACUTE RESULTS AND CLINICAL OUTCOMES.
The acute results of primary PCI with the EES were also comparable between groups (Tables 2 and 3 ). At 9-month follow-up, the stent parameters were not significantly different between groups. Importantly, independent of the lesion morphology, we observed low levels of neointima obstruction, high rates of Values are median (interquartile range), n (%), or n. *Number of TCFAs observed along the scanned segment into the culprit vessel, outside the culprit lesion. †No differences were observed between IFC and RFC in terms of not analyzed frames and struts, both post-stenting and at 9-month follow-up (data not reported).
NIH ¼ neointimal hyperplasia; TCFA ¼ thin-cap fibroatheroma; other abbreviations as in Table 1. strut coverage, and minimal rates of late malapposition ( Table 3) . At 1-and 2-year follow-up, the incidence of major adverse cardiac or cerebrovascular events was low, without statistically significant differences between the 2 study groups ( Table 5 , Figure 2 ). Stent thrombosis (subacute) occurred in only 1 patient in the RFC group.
DISCUSSION
The principal findings of this study are the First, in our study that included patients of all ages and considered only culprit plaques with a clearly identified morphology, the incidence of IFC was 33%, whereas RFC was observed in 64.9%. This observation is consistent with pathology series and smaller OCT studies (3, 6, 10, 19) . Calcified nodules, i.e., nodular calcifications protruding into the lumen and described as a rare cause of coronary thrombosis in autopsy series, were not identified in our series. A plausible explanation can be found in the exclusion of patients with heavily calcified and tortuous coronary arteries (12) , which are more likely to present calcified nodules (3). Nevertheless, our findings are consistent with no evidence of calcified nodules as culprit plaque in STEMI patients reported in vivo by others using OCT (20) . In addition, calcific nodules were not shown to be related to future cardiovascular events in the prospective PROSPECT (Providing Regional Observa-
tions to Study Predictors of Events in the Coronary
Tree) study (21) .
Second, we compared clinical characteristics and blood biomarkers between patients with IFC and those with RFC and found no significant difference in all analyzed parameters (Tables 1 and 4) . Plaque erosion has been observed in ex vivo studies more frequently in females and young individuals (3, 6) . In the main report from the OCTAVIA trial, we found that, when age matched, STEMI men and women did MACCE ¼ major adverse cardiac or cerebrovascular events; TLR ¼ target lesion revascularization; other abbreviations as in Table 1 . Previous studies found higher levels of serum MPO in patients with IFC compared with those with RFC, raising the hypothesis that increases in selective inflammatory biomarkers might be associated with different plaque morphologies (22) . In our study, we did not observe significant differences in blood biomarkers of inflammation and platelet activation between patients with IFC and RFC, including MPO, suggesting that patient selection biases may be responsible for many of the observed discrepancies across studies (3).
Third, the presence of endoluminal thrombus initially detected by OCT at the culprit site was high in both groups but significantly lower in IFC compared with RFC, with less residual white and red clot volume after thrombus aspiration in the IFC group ( Table 3) . This is not surprising because in RFC, the exposed necrotic core is highly thrombo- Fourth, an important finding of our study is that there was not a significantly different vascular response to the EES between groups. Indeed, quantitative coronary analysis and OCT parameters at 9-month follow-up were very similar, including late lumen loss, diameter stenosis, neointimal area, stent strut coverage, and malapposition (Tables 2 and 3) .
Whether plaque morphology underlying STEMI should lead to a different therapeutic approach remains speculative. Previous studies suggested that OCT may identify patients with eroded, subcritically occlusive plaque that can be treated with thrombectomy alone without stenting (4, 5) . In the present study, IFC and RFC showed similar degrees of stenosis and a high incidence of residual endoluminal thrombus after manual thrombectomy, raising doubts about a different treatment strategy. Furthermore, vascular response to the EES was excellent and similar in both groups.
STUDY LIMITATIONS. First, the population enrolled was not representative of a high-risk STEMI cohort, and a number of patients could not be included.
The study was, in fact, designed to avoid any unnecessary delay due to OCT pullback before restoring myocardial reperfusion, and patients were not enrolled if good coronary flow could not be obtained with thrombus aspiration only. Second, 24% of lesions had indeterminate morphology on OCT. However, this was essentially due to the strict quality criteria applied by the OCT core laboratory, and comparable rates were found by other authors (20) . Third, the extent to which OCT can identify all features recognized by pathology remains to be verified. Although the identification of RFC with OCT has a high level of evidence (13), IFC can be classified with a lower level of confidence, and its definition is Table 5 has only a descriptive purpose.
CONCLUSIONS
In the present study, an IFC consistent with plaque erosion was observed at the culprit lesion site in onethird of patients with STEMI. IFC compared with RFC was associated with higher rates of patent IRA at first angiography, fewer lipid areas, and endoluminal thrombus. However, no difference in vascular response to EES was observed. 
